Published on 18 Mar 2024 on Zacks via Yahoo Finance
Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates
Tango Therapeutics, Inc. (TNGX) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -14.29%. A quarter ago, it was expected that this company would post a loss of $0.34 per share when it actually produced a loss of $0.23, delivering a surprise of 32.35%.
Over the last four quarters, the company has surpassed consensus EPS estimates three times.